Processing and localization of the african swine fever virus CD2v transmembrane protein.
The African swine fever virus (ASFV)-encoded CD2v transmembrane protein is required for the hemadsorption of red blood cells around infected cells and is also required for the inhibition of bystander lymphocyte proliferation in response to mitogens. We studied the expression of CD2v by expressing the gene with a V5 tag downstream from the signal peptide near the N terminus and a hemagglutinin (HA) tag at the C terminus. In ASFV-infected cells, a full-length glycosylated form of the CD2v protein, which migrated mainly as a 89-kDa product, was detected, as well as an N-terminal glycosylated fragment of 63 kDa and a C-terminal nonglycosylated fragment of 26 kDa. All of these forms of the protein were localized in the membrane fraction of cells. The 26-kDa C-terminal fragment was also produced in infected cells treated with brefeldin A. These data indicate that the CD2v protein is cleaved within the luminal domain and that this occurs in the endoplasmic reticulum or Golgi compartments. Confocal microscopy showed that most of the expressed CD2v protein was localized within cells rather than at the cell surface. Comparison of the localization of full-length CD2v with that of a deletion mutant lacking all of the cytoplasmic tail apart from the 12 membrane-proximal amino acids indicated that signals within the cytoplasmic tail are responsible for the predominant localization of the full-length and C-terminal 26-kDa fragment within membranes around the virus factories, which contain markers for the Golgi compartment. Processing of the CD2v protein was not observed in uninfected cells, indicating that it is induced by ASFV infection.
Institute for Animal Health, Pirbright Laboratory, Ash Road, Pirbright, Surrey GU24 0NF, United Kingdom.
Lynnette C
LC
Goatley
Linda K
LK
Dixon
D000358:African Swine Fever Virus / Q000502:physiology*; D000595:Amino Acid Sequence; D000818:Animals; D002462:Cell Membrane / Q000737:chemistry; D002522:Chlorocebus aethiops; D003593:Cytoplasm / Q000737:chemistry; D004721:Endoplasmic Reticulum / Q000378:metabolism; D006031:Glycosylation; D008565:Membrane Proteins / Q000737:chemistry / Q000378:metabolism*; D018613:Microscopy, Confocal; D008969:Molecular Sequence Data; D008970:Molecular Weight; D010447:Peptide Hydrolases / Q000378:metabolism; D011499:Protein Processing, Post-Translational; D016415:Sequence Alignment; D014709:Vero Cells; D014764:Viral Proteins / Q000737:chemistry / Q000378:metabolism*
D008565:Membrane Proteins; D014764:Viral Proteins; D010447:Peptide Hydrolases
Virology. 2009 Oct 25;393(2):319-28
19729182
Onderstepoort J Vet Res. 1979 Sep;46(3):149-54
551362
J Virol. 1998 Mar;72(3):2373-87
9499098
Virology. 2000 Jan 20;266(2):340-51
10639320
Biochem Biophys Res Commun. 2003 Feb 14;301(3):704-10
12565838
J Biol Chem. 2003 Dec 26;278(52):52195-202
14557276
Curr Top Microbiol Immunol. 2009;328:43-87
19216435
Int Immunol. 1991 Feb;3(2):165-74
2025617
J Virol. 1993 Sep;67(9):5312-20
8102411
Mol Biol Cell. 2010 Jan 1;21(1):186-97
19910490
J Gen Virol. 1988 Dec;69 ( Pt 12):2981-93
3199101
J Gen Virol. 2004 Jan;85(Pt 1):119-130
14718626
Am J Vet Res. 1986 May;47(5):1125-31
3521406
Mol Cell Biol. 2005 Aug;25(16):6869-78
16055701
J Virol. 1996 Dec;70(12):8382-90
8970959
Mol Biol Cell. 2000 Jan;11(1):393-412
10637315
J Exp Med. 1993 Aug 1;178(2):549-58
7688025
J Exp Med. 1992 Nov 1;176(5):1241-9
1383383
Nature. 1987 Oct 29-Nov 4;329(6142):842-6
2444890
J Biol Chem. 2003 May 30;278(22):20268-77
12654920
Immunol Rev. 2001 Dec;184:69-81
12086322
Philos Trans R Soc Lond B Biol Sci. 2009 Sep 27;364(1530):2683-96
19687038
J Virol. 1998 Apr;72(4):2881-9
9525608
Structure. 1994 Aug 15;2(8):755-66
7994575
J Cell Biol. 2001 Apr 16;153(2):351-66
11309416
J Gen Virol. 2004 Aug;85(Pt 8):2177-2187
15269356
J Gen Virol. 2001 Mar;82(Pt 3):513-523
11172092
J Biol Chem. 1990 May 25;265(15):8542-9
1971273
Immunology. 1999 Mar;96(3):389-95
10233720